OncologyOnline.net

Oncology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Vandetanib"

AstraZeneca announced today that it has withdrawn the regulatory submissions for the use of ZACTIMA ( Vandetanib ) 100mg in combination with chemotherapy in patients with advanced non-small cell lung ...